AstraZeneca

aid: astrazeneca
url: https://raw.githubusercontent.com/api-evangelist/astrazeneca/refs/heads/main/apis.yml
name: AstraZeneca
type: Index
accessModel:
  pricing: unknown
  onboarding: approval
  trial: false
  try_now: false
  public: false
  label: Requires approval
  confidence: medium
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/astrazeneca.png
tags:
- Pharmaceutical
- Biotechnology
- Healthcare
description: AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company focused on oncology,
  cardiovascular, renal, metabolism, and respiratory therapies. AstraZeneca does not publish a general developer portal or
  commercial public APIs; technology integration is delivered through enterprise partner programs, clinical trial data portals
  such as clinicaltrials.gov and the Vivli platform, and EDI/x12 channels used by distributors and pharmacy benefit managers.
created: '2026-05-05'
modified: '2026-05-16'
specificationVersion: '0.19'
apis: []
common:
- type: DomainSecurity
  url: security/astrazeneca-domain-security.yml
- type: GitHubOrganization
  url: https://github.com/AstraZeneca
- type: LinkedIn
  url: https://www.linkedin.com/company/astrazeneca
- type: Website
  url: https://www.astrazeneca.com/
- type: ClinicalTrials
  url: https://www.astrazenecaclinicaltrials.com/
- type: DataSharing
  url: https://www.astrazenecaclinicaltrials.com/transparency/data-sharing/
- type: Partnerships
  url: https://www.astrazeneca.com/partnerships.html
- type: Suppliers
  url: https://www.astrazeneca.com/suppliers.html
- type: PrivacyPolicy
  url: https://www.astrazeneca.com/legal/integrated-privacy-notice.html
- type: TermsOfService
  url: https://www.astrazeneca.com/legal/terms-of-use.html
- type: Contact
  url: https://www.astrazeneca.com/contact-us.html
- type: Features
  data:
  - name: Clinical Trial Information
    description: Clinical trial registrations and results are publicly accessible via clinicaltrials.gov, the EU Clinical
      Trials Register, and AstraZeneca's own trial site.
  - name: Patient-Level Data Sharing
    description: Anonymized patient-level clinical trial data is made available to qualified researchers through the Vivli
      platform.
  - name: Medical Information Portal
    description: Healthcare professionals can request product and safety information via country-specific medical information
      sites.
  - name: Distributor and Wholesaler EDI
    description: Drug ordering, returns, chargebacks, and shipment notifications are exchanged with distributors via standardized
      x12 EDI transactions.
  - name: Pharmacovigilance Submissions
    description: Adverse-event reports are received via regulatory channels (E2B, FAERS) rather than a public API.
- type: UseCases
  data:
  - name: Clinical Research Data Discovery
    description: Find and link AstraZeneca-sponsored studies into clinical research and evidence-generation platforms.
  - name: Pharma Supply Chain Integration
    description: Distributors integrate order, shipment, and chargeback flows with AstraZeneca's commercial supply chain via
      EDI.
  - name: Medical Affairs Engagement
    description: HCPs and medical-information vendors retrieve dosing, contraindication, and interaction information for clinical
      decision support.
  - name: Real-World Evidence Studies
    description: Researchers use the Vivli platform to combine AstraZeneca trial data with external real-world evidence sources.
- type: Compliance
  data:
  - name: HIPAA
    description: U.S. operations involving protected health information are subject to HIPAA Privacy and Security Rules.
  - name: GDPR
    description: European patient and trial data handling is governed by the EU General Data Protection Regulation.
  - name: FDA 21 CFR Part 11
    description: Electronic records and signatures supporting AstraZeneca's regulated processes follow FDA 21 CFR Part 11
      requirements.
  - name: GxP (GMP / GCP / GLP / GVP)
    description: Manufacturing, clinical, lab, and pharmacovigilance practices follow applicable Good Practice standards.
  - name: ICH E2B
    description: Adverse-event reporting follows the ICH E2B(R3) standard for individual case safety reports.
plansReconciled: false
rateLimitsReconciled: false
finopsReconciled: false
position: Consuming
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com